Complex proteins require more than process execution—they require scientific problem-solving.
A fit-for-purpose strategy considers every aspect of the molecule, from construct design and host selection to purification, characterization, and long-term stability. This targeted approach helps generate proteins that are not only expressed successfully but are also biologically relevant, functional, and reproducible.
Whereas membrane proteins make up ∼23% of the human proteome, it is estimated that membrane proteins constitute more than 60% of current drug targets. Hence this makes membrane proteins such an important target among drug companies for their drug discvery process strategies. Despite being central to cellular signalling, transport, and communication—and representing some of the most important drug targets—these proteins remain among the most difficult to produce and characterize. Their low expression levels, poor stability outside the native membrane environment, and complex purification requirements frequently create bottlenecks in drug discovery programs.
For sponsors, these challenges can translate into extended development timelines, repeated optimization efforts, and uncertainty regarding protein quality and functionality.
Overcoming such barriers requires an integrated approach that addresses the entire workflow—from expression and solubilization to purification and analytical characterization—rather than focusing on a single step in isolation.
At Aragen, we overcome these challenges through an integrated recombinant membrane protein platform that leverages the most suitable expression system—bacterial, yeast, insect, and mammalian —for every target.
Our capabilities span comprehensive detergent screening, advanced purification workflows, and robust analytical characterization to ensure protein quality, stability, and functionality.
By combining scientific expertise with cutting-edge technologies, Aragen enables researchers to accelerate structural biology, biophysics, and assay development.
Our experience spans diverse membrane protein classes, including GPCRs, B-lymphocyte-specific membrane proteins, and mitochondrial ABC transporters. Through optimized expression strategies, customized solubilization workflows, and purification approaches tailored to target-specific requirements, we deliver high-quality membrane proteins suitable for demanding downstream applications.
A fit-for-purpose strategy delivers value far beyond protein production. High-quality, well-characterized proteins help improve reproducibility, support robust assay development, and enable more reliable structural and biophysical studies. Most importantly, they provide the confidence required to make informed scientific and investment decisions.
By reducing technical uncertainties early, sponsors can minimize costly rework, accelerate project progression, and focus resources on advancing promising therapeutic candidates rather than troubleshooting protein-related challenges.
As biologics targets continue to grow in complexity, standardized approaches are increasingly becoming a limiting factor. Success depends on matching the development strategy to the biology of the target.
By combining deep expertise in complex proteins with flexible technology platforms and customized workflows, Aragen helps transform challenging targets into actionable discovery opportunities—enabling sponsors to move from scientific complexity to confident decision-making faster.
Ready to overcome complex protein challenges? Partner with Aragen to accelerate discovery with tailored protein production strategies.
